(firstQuint)Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity.

 Preterm neonates who start receiving enteral feeding will receive the intervention with docosahexaenoic acid (DHA) since the first day and throughout 14 days, one dose per day.

 The opthalmic evaluation will be done after 4-5 weeks after birth and followed until 42-45 corrected gestational age.

.

 Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity@highlight

The purpose of this study is to evaluate whether docosahexaenoic acid given by enteral feeding prevent retinopathy of prematurity and/or diminish its severity in preterm infants.

